Sarepta therapeutics announces preliminary financial results for the third quar-ter ended september 30, 2021

Cambridge, mass., oct. 12, 2021 (globe newswire) -- sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, today announced preliminary financial results for its third quarter ended september 30, 2021.
SRPT Ratings Summary
SRPT Quant Ranking